HomeCompareRSLS vs GBDC

RSLS vs GBDC: Dividend Comparison 2026

RSLS yields 51.02% · GBDC yields 11.86%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 GBDC wins by $20.43M in total portfolio value· pulled ahead in Year 6
10 years
RSLS
RSLS
● Live price
51.02%
Share price
$3.92
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$415.3K
Annual income
$85,519.64
Full RSLS calculator →
GBDC
GBDC
● Live price
11.86%
Share price
$12.65
Annual div
$1.50
5Y div CAGR
51.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.85M
Annual income
$16,450,733.83
Full GBDC calculator →

Portfolio growth — RSLS vs GBDC

📍 GBDC pulled ahead of the other in Year 6

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodRSLSGBDC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, RSLS + GBDC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
RSLS pays
GBDC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

RSLS
Annual income on $10K today (after 15% tax)
$4,336.73/yr
After 10yr DRIP, annual income (after tax)
$72,691.69/yr
GBDC
Annual income on $10K today (after 15% tax)
$1,007.91/yr
After 10yr DRIP, annual income (after tax)
$13,983,123.76/yr
At 15% tax rate, GBDC beats the other by $13,910,432.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of RSLS + GBDC for your $10,000?

RSLS: 50%GBDC: 50%
100% GBDC50/50100% RSLS
Portfolio after 10yr
$10.63M
Annual income
$8,268,126.74/yr
Blended yield
77.76%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on GBDC right now

RSLS
Analyst Ratings
1
Buy
2
Hold
Consensus: Hold
Altman Z
-24.1
Piotroski
3/9
GBDC
Analyst Ratings
6
Buy
5
Hold
Consensus: Buy
Price Target
$14.00
+10.7% upside vs current
Range: $13.00 — $15.00
Altman Z
0.6
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

RSLS buys
0
GBDC buys
0
No recent congressional trades found for RSLS or GBDC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricRSLSGBDC
Forward yield51.02%11.86%
Annual dividend / share$2.00$1.50
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%51.1%
Portfolio after 10y$415.3K$20.85M
Annual income after 10y$85,519.64$16,450,733.83
Total dividends collected$332.9K$20.43M
Payment frequencyquarterlyquarterly
SectorStockBDC
Analyst consensusHoldBuy

Year-by-year: RSLS vs GBDC ($10,000, DRIP)

YearRSLS PortfolioRSLS Income/yrGBDC PortfolioGBDC Income/yrGap
1$15,802$5,102.04$12,492$1,791.70+$3.3KRSLS
2$24,443$7,534.83$16,527$3,160.58+$7.9KRSLS
3$37,047$10,892.59$23,588$5,904.90+$13.5KRSLS
4$55,069$15,429.12$37,141$11,901.65+$17.9KRSLS
5$80,358$21,434.63$66,205$26,463.38+$14.2KRSLS
6← crossover$115,215$29,231.87$137,452$66,612.65$22.2KGBDC
7$162,450$39,169.84$342,372$195,298.53$179.9KGBDC
8$225,437$51,615.25$1,053,292$686,954.33$827.9KGBDC
9$308,160$66,942.06$4,111,439$2,984,416.95$3.80MGBDC
10$415,251$85,519.64$20,849,974$16,450,733.83$20.43MGBDC

RSLS vs GBDC: Complete Analysis 2026

RSLSStock

ReShape Lifesciences Inc., a medical device company, provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; and ReShape Vest system, an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the stomach to enable weight loss in obese and morbidly obese patients without cutting or permanently removing portions of the stomach, or bypassing any portion of the gastrointestinal tract. It also offers ReShapeCare virtual health coaching program, a virtual telehealth weight management program that supports healthy lifestyle changes for all medically managed weight-loss patients; and ReShape Diabetes Bloc-Stim Neuromodulation, a technology that is in preclinical development for the treatment of type 2 diabetes mellitus. In addition, the company provides Obalon Balloon System, a swallowable capsule used to track and display the location of the balloon during placement. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in San Clemente, California.

Full RSLS Calculator →

GBDCBDC

Golub Capital BDC, Inc. (GBDC) is a business development company and operates as an externally managed closed-end non-diversified management investment company. It invests in debt and minority equity investments in middle-market companies that are, in most cases, sponsored by private equity investors. It typically invests in diversified consumer services, automobiles, healthcare technology, insurance, health care equipment and supplies, hotels, restaurants and leisure, healthcare providers and services, IT services and specialty retails. It seeks to invest in the United States. It primarily invests in first lien traditional senior debt, first lien one stop, junior debt and equity, senior secured, one stop, unitranche, second lien, subordinated and mezzanine loans of middle-market companies, and warrants.

Full GBDC Calculator →
📬

Get this RSLS vs GBDC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

RSLS vs SCHDRSLS vs JEPIRSLS vs ORSLS vs KORSLS vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.